Synektik

Synektik FCF per Share

The Free Cash Flow per Share of Synektik (SNT.WA) as of Oct 31, 2026 is 6.99 PLN. In the previous year, Free Cash Flow per Share was 5.25 PLN — a change of 33.19% (higher).

FCF per Share

6.99PLN

YoY

33.19%

Last updated:

Free Cash Flow per Share of Synektik is 2025 6.99 PLN. Free Cash Flow per Share of Synektik was 2024 5.25 PLN. It decreases by 33.19% higher compared to the previous year.

The Synektik FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
0.33 PLN
Jan 1, 2019
0.94 PLN
Jan 1, 2020
1.03 PLN
Jan 1, 2021
2.14 PLN
Jan 1, 2022
-1.92 PLN
Jan 1, 2023
10.11 PLN
Jan 1, 2024
5.25 PLN
Jan 1, 2025
6.99 PLN
The Synektik FCF per Share history
YEARFCF per ShareYoY
6.99PLN+33.19%
5.25PLN-48.10%
10.11PLN-625.43%
-1.92PLN-189.74%
2.14PLN+107.42%
1.03PLN+9.71%
0.94PLN+181.83%
0.33PLN-63.83%
0.92PLN-152.39%
-1.76PLN+209.68%
-0.57PLN+53.91%
-0.37PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Free Cash Flow per Share of Synektik is 6.99 PLN in 2025.

Free Cash Flow per Share of Synektik changed from 5.25 PLN to 6.99 PLN, representing a 33.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Synektik since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Synektik

All Key Metrics — Synektik